InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 06/10/2019 2:00:47 PM

Monday, June 10, 2019 2:00:47 PM

Post# of 333
News: $ZFGN Zafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Association's 79th Scientific Sessions

Delivered comprehensive oral presentation on both cohorts of the clinical trial, including previously announced results for second cohort evaluating doses up to 1.8 mg Company also presented data demonstrating that treatment with ZGN-1061 improves measures of insulin sensitivity and b...

Find out more https://marketwirenews.com/news-releases/zafgen-presented-full-results-of-phase-2-clinical-trial-for-zgn-1061-at-the-american-diabetes-association-s-79th-scientific-sessions-8329472.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LRMR News